Related Experiment Video
Updated: Dec 28, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.2K
2019: A Banner Year for Tuberculosis Research.
Robert W Eisinger1, Alan C Embry2, Sarah W Read3
1Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
The Journal of Infectious Diseases
|February 12, 2020
Summary
Significant 2019 scientific advancements offer new tuberculosis (TB) drugs, vaccines, and diagnostics. Continued research and collaborative efforts are crucial in 2020 to implement these tools and end TB within a generation.
Area of Science:
- Tuberculosis research
- Infectious disease therapeutics
- Vaccinology
- Diagnostic development
Background:
- Tuberculosis (TB) remains a major global health challenge.
- 2019 saw notable scientific progress in TB prevention and treatment.
- Urgent need for improved tools and interventions to combat TB.
Purpose of the Study:
- To review significant scientific advancements in TB research from 2019.
- To highlight progress in developing new drugs, vaccines, and diagnostics for TB.
- To emphasize the need for continued research and implementation efforts.
Main Methods:
- Review of scientific literature and reported progress in 2019.
- Analysis of developments in drug discovery, vaccine candidates, and diagnostic tools.
- Synthesis of findings to inform future research and control strategies.
Main Results:
- Development of novel drug and therapeutic regimens for TB.
- Advancement of promising vaccine candidates for TB prevention.
- Progress in creating new diagnostic tools for TB detection and management.
Conclusions:
- 2019 marked substantial scientific progress against tuberculosis.
- Sustained momentum in research and development is vital for 2020.
- A collaborative, multi-sectoral approach is essential to eradicate TB.
More Related Videos
Related Concept Videos
01:26Pulmonary Tuberculosis IV
439
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
439
01:29Pulmonary Tuberculosis I
762
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
762
01:28Pulmonary Tuberculosis V
488
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
488
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:31Pulmonary Tuberculosis III
822
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
822